Review
Open access
Jul 2026
Gut Microbiome Dysbiosis in Atopic Dermatitis: Pathogenic Mechanisms, Gut–Skin Axis Disruption, and Emerging Microbiota-Targeted Therapies
Current evidence supports the gut microbiome as a mechanistically plausible contributor, potential biomarker, and therapeutic target in AD while underscoring the need for longitudinal, phenotype-aware, and externally validated studies before routine clinical translation.
L. Boldeanu, A. Ghenea, Marius-Bogdan Novac et al.
· Biomedicines · 0 citations